NIH 研究发现，镰状细胞性状携带者出现血栓的风险增加了 1.45 倍，在不同人群中是一致的。 NIH study finds 1.45-fold increased risk of blood clots in sickle cell trait carriers, consistent across diverse populations.
NIH 研究人员的一项研究发现，具有镰状细胞性状（镰状细胞病的携带者）的个体患静脉血栓（包括肺栓塞）的风险增加了 1.45 倍。 A study by NIH researchers has found that individuals with sickle cell trait, a carrier status for sickle cell disease, face a 1.45-fold increased risk of venous blood clots, including pulmonary embolism. 这种风险在不同的人群中是始终如一的,不仅仅是那些传统上与镰状细胞疾病有关的人群。 This risk is consistent across diverse populations, not just those traditionally linked to sickle cell disease. 这些调查结果发表在《血液进步》中,目的是加强临床实践准则,并向受影响个人通报手术和住院的风险。 Published in Blood Advances, these findings aim to enhance clinical practice guidelines and inform risks for surgeries and hospitalizations among affected individuals.